IL-12-impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation

Journal of Immunology

Volumn 180, Issue 10, 2008, Pages 6629-6639

  Jasny, Edith ^a   Eisenblätter, Martin ^a   Mätz Rensing, Kerstin ^c   Tenner Racz, Klara ^d   Tenbusch, Matthias ^e   Schrod, Annette ^c   Stahl Hennig, Christiane ^c   Moos, Verena ^b   Schneider, Thomas ^b   Racz, Paul ^c   Überla, Klaus ^e   Kaup, Franz Josef ^c   Ignatius, Ralf ^a,b  

^a Department of Infection Immunology ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CD40 LIGAND; GAMMA INTERFERON; GLATIRAMER; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; CYTOKINE; IMMUNOLOGICAL ADJUVANT; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FOXP3+ REGULATORY T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; CELLULAR IMMUNITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACACA; METABOLISM; PHOSPHORYLATION; SECRETION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; BUCLADESINE; CD40 LIGAND; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; INTERLEUKIN-23; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MICROSCOPY, FLUORESCENCE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION;

EID: 45549085054     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.10.6629     Document Type: Article

References (83)

1. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748.
2. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
3. Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Krueger. 2004. Increased expression of interleukin 23 pl9 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199: 125-130.
4. Yen, D., J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M. A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116: 1310-1316.
5. Agganval, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of inteleukin-17. J. Biol. Chem. 278: 1910-1914.
6. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Anna. Rev. Immunol. 25: 821-852.
7. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
8. Peters, J. H., H. Xu, J. Ruppert, D. Ostermeier, D. Friedrichs, and R. K. Gieseler. 1993. Signals required for differentiating dendritic cells from human monocytes in vitro. Adv. Exp. Med. Biol. 329: 275-280.
9. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
10. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
11. Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmilt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27: 3135-3142.
12. Schnurr, M., T. Toy, A. Shin, M. Wagner, J. Cebon, and E. Maraskovsky. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105: 1582-1589.
13. Lee, A. W., T. Truong, K. Bickham, J. F. Fonteneau, M. Larsson, I. Da Silva, S. Somersan, E. K. Thomas, and N. Bhardwaj. 2002. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 20 (Suppl. 4): A8-A22.
14. Schuler-Thumer, B., E. S. Schultz, T. G. Berger, G. Weinlich, S. Ebner, P. Woerl, A. Bender, B. Feuerstein, P. O. Fritsch, N. Romani, and G. Schuler. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195: 1279-1288.
15. Nestle, F. O., A. Farkas, and C. Conrad. 2005. Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 17: 163-169.
16. Gilboa, E. 2007. DC-based cancer vaccines. J. Clin. Invest. 117: 1195-1203.
17. Duda, P. W., M. C. Schmied, S. L. Cook, J. I. Krieger, and D. A. Hafler. 2000. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 105: 967-976.
18. Pulendran, B., P. Kumar, C. W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167: 5067-5076.
19. Vieira, P. L., H. C. Heystek, J. Wormmeester, E. A. Wierenga, and M. L. Kapsenberg. 2003. Glatiramer acetate (copolymer-I, Copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170: 4483-4488.
20. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, T. R. Fouls, and G. K. Lewis. 2002. Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect. Immun. 70: 5533-5539.
21. Gagliardi, M. C., F. Sallusto, M. Marinaro, A. Langenkamp, A. Lanzavecchia, and M. T. De Magistris. 2000. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30: 2394-2403.
22. Liu, Y. J., N. Kadowaki, M. C. Rissoan, and V. Soumelis. 2000. T cell activation and polarization by DC1 and DC2. Curr. Top. Microbiol. Immunol. 251: 149-159.
23. Desrosiers, R. C. 1990. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8: 557-578.
24. Nehete, P. N., S. Chitta, M. M. Hossain, L. Hill, B. J. Bernacky, W. Baze, R. B. Arlinghaus, and K. J. Sastry. 2001. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Vaccine 20: 813-825.
25. Goulder, P. J., and D. I. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4: 630-640.
26. O'Doherty, U., R. Ignatius, N. Bhardwaj, and M. Pope. 1997. Generation of monocyte-derived dendritic cells from precursors in rhesus macaque blood. J. Immunol. Methods 207: 185-194.
27. Mehlhop, E., L. A. Villamide, I. Frank, A. Gettie, C. Santisteban, D. Messmer, R. Ignatius, J. D. Lifson, and M. Pope. 2002. Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J. Immunol. Methods 260: 219-234.
28. Villamide-Herrera, L., R. Ignatius, M. A. Eller, K. Wilkinson, C. Griffin, E. Mehlhop, J. Jones, S. Y. Han, M. G. Lewis, S. Parrish, et al. 2004. Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo. AIDS Res. Hum. Retroviruses 20: 871-884.
29. Zhu, Y., K. Koo, J. D. Bradshaw, W. F. Sutton, L. R. Kuller, R. Bucala, D. Anderson, S. P. Mossman, F. Villinger, and N. L. Haigwood. 2000. Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses. J. Med. Primatol. 29: 182-192.
30. Barratt-Boyes, S. M., M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano, III, M. Murphey-Corb, L. D. Falo, Jr., and A. D. Donnenberg. 2000. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164: 2487-2495.
31. Brown, K., W. Gao, S. Alber, A. Trichel, M. Murphey-Corb, S. C. Watkins, A. Gambotto, and S. M. Barratt-Boyes. 2003. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys. J. Immunol. 171: 6875-6882.
32. Lu, W., X. Wu, Y. Lu, W. Guo, and J. M. Andrieu. 2003. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 9: 27-32.
33. Lekkerkerker, A. N., Y. Van Kooyk, and T. B. Geijtenbeek. 2004. Mucosaltargeted AIDS vaccines: the next generation? Trends Microbiol. 12: 447-450.
34. de Vries, I. J., W. J. Lesterhuis, N. M. Scharenborg, L. P. Engelen, D. J. Ruiter, M. J. Gerritsen, S. Croockewit, C. M. Britten, R. Torensma, G. J. Adema, et al. 2003. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin. Cancer Res. 9: 5091-5100.
35. de Vries, I. J., D. J. Krooshoop, N. M. Scharenborg, W. J. Lesterhuis, J. H. Diepstra, G. N. Van Muijen, S. P. Strijk, T. J. Ruers, O. C. Boerman, W. J. Oyen, et al. 2003. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63: 12-17.
36. Dhodapkar, M. V., R. M. Steinman, M. Sapp, H. Desai, C. Fossella, J. Krasovsky, S. M. Donahoe, P. R. Dunbar, V. Cerundolo, D. F. Nixon, and N. Bhardwaj. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104: 173-180.
37. + T-cell in humans without foreign helper epitopes. J. Clin. Invest. 105: R9-R14.
38. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
39. Jonuleit, H., A. Giesecke-Tuettenberg, T. Tuting, B. Thurner-Schuler, T. B. Stuge, L. Paragnik, A. Kandemir, P. P. Lee, G. Schuler, J. Knop, and A. H. Enk. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93: 243-251.
40. + regulatory T cells in vivo in humans. Blood 100: 174-177.
41. Verhasselt, V., O. Vosters, C. Beuneu, C. Nicaise, P. Stordeur, and M. Goldman. 2004. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur. J. Immunol. 34: 762-772.
42. Wing, K., Z. Fehervari, and S. Sakaguchi. 2006. Emerging possibilities in the development and function of regulatory T cells. Int. Immunol. 18: 991-1000.
43. + T cell memory responses. J. Immunol. 172: 6047-6056.
44. + T cell responses to protein antigens in rhesus macaques in vivo. Vaccine 23: 3310-3317.
45. + T cell responses in rhesus macaques. J. Immunol. Methods 288: 61-79.
46. Ignatius, R., M. Marovich, E. Mehlhop, L. Villamide, K. Mahnke, W. I. Cox, F. Isdell, S. S. Frankel, J. R. Mascola, R. M. Steinman, and M. Pope. 2000. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. J. Virol. 74: 11329-11338.
47. Gilliet, M., M. Kleinhans, E. Lantelme, D. Schadendorf, G. Burg, and F. O. Nestle. 2003. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood 102: 36-42.
48. + regulatory T cells. Nat. Immunol. 4: 330-336.
49. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
50. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
51. Martin-Fontecha, A., S. Sebastiani, U. E. Hopken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
52. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
53. Garrelt, W. S., L. M. Chen, R. Kroschewski, M. Ebersold, S. Turley, S. Trombetta, J. E. Galan, and I. Mellman. 2000. Developmental control of en-docytosis in dendritic cells by Cdc42. Cell 102: 325-334.
54. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93.
55. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135.
56. Ridolfi, R., A. Riccobon, R. Galassi, G. Giorgetti, M. Petrini, L. Fiammenghi, M. Stefanelli, L. Ridolfi, A. Moretti. G. Migliori, and G. Fiorentini. 2004. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J. Transl. Med. 2: 27.
57. Hunter, C. A. 2005. New IL-12-family members:IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
58. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-I2 production by human dendritic cells requires two signals. Int. Immunol. 10: 1593-1598.
59. 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p7O heterodimer. Blood 97: 3466-3469.
60. Cooper, A. M., and S. A. Khader. 2007. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28: 33-38.
61. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158: 4129-4136.
62. Jankovic, D., P. Caspar, M. Zweig, M. Garcia-Moll, S. D. Showalter, F. R. Vogel, and A. Sher. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gpl20. J. Immunol. 159: 2409-2417.
63. Kuipers, H., C. Heirman, D. Hijdra, F. Muskens, M. Willart, S. Van Meirvenne, K. Thielemans, H. C. Hoogsteden, and B. N. Lambrecht. 2004. Dendritic cells relrovirally overexpressing IL-12 induce strong Thl responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. J. Leukocyte Biol. 76: 1028-1038.
64. Brand, U., I. Bellinghausen, A. H. Enk, H. Jonuleit, D. Becker, J. Knop, and J. Saloga. 1998. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 28: 1673-1680.
65. Lehner, M., P. Morhart, A. Stilper, D. Petermann, P. Weller, D. Stachel, and W. Holter. 2007. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors. J. Immunother. 30: 312-322.
66. + T cell-induced colitis. Eur. J. Immunol. 33: 1073-1083.
67. Uhlig, H. H., B. S. McKenzie, S. Hue, C. Thompson, B. Joyce-Shaikh, R. Stepankova, N. Robinson, S. Buonocore, H. Tlaskalova-Hogenova, D. J. Cua, and F. Powrie. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25: 309-318.
68. 2 regulates the migratory capacity of specific DC subsets. Blood 100: 1362-1372.
69. 2. Blood 103: 1595-1601.
70. 2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176: 966-973.
71. 2 and nitric oxide. Clin. Vaccine Immunol. 13: 106-115.
72. Casanova, J. L., and L. Abel. 2004. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4: 55-66.
73. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel pl9 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
74. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175: 788-795.
75. Wozniak, T. M., A. A. Ryan, and W. J. Britton. 2006. Interleukin-23 restores immunity to Mycobacerium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 177: 8684-8692.
76. Fedele, G., P. Stefanelli, F. Spensieri, C. Fazio, P. Mastrantonio, and C. M. Ausiello. 2005. Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Thl polarization and interleukin-23 expression. Infect. Immun. 73: 1590-1597.
77. Spensieri, F., G. Fedele, C. Fazio, M. Nasso, P. Stefanelli, P. Mastrantonio, and C. M. Ausiello. 2006. Bordelella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect. Immun. 74: 2831-2838.
78. Hoeve, M. A., N. D. Savage, T. de Boer, D. M. Langenberg, R. de Waal Malefyt, T. H. Ottenhoff, and F. A. Verreck. 2006. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36: 661-670.
79. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
80. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, E. M. Shevach, and J. O'Shea. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
81. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957.
82. high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661.
83. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50.